XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2

Loss per Share (Tables)

9 Months Ended

Sep. 30, 2022

Loss per Share

Schedule of anti-dilutive common equivalent shares

​

​	​	​	​	​
​	​	Nine months ended	​	Nine months ended
​	​	September 30,	​	September 30,
​		2022		2021
Outstanding options to purchase common shares	​	25,140,262		25,287,670
Outstanding RSUs	​	5,021,783		56,224
Outstanding shares under ESPP	​	34,116	​	—
Outstanding warrants	​	36,078,620	​	36,078,620
Outstanding Special Shares and options to purchase Special Shares	​	136,239,964	​	136,239,964
Total anti-dilutive common equivalent shares	​	202,514,745		197,662,478

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration